TY - JOUR AU - Farinha, N. J. AU - Razali, K. A. AU - Holzel, H. AU - Morgan, G. AU - Novelli, V. M. PY - 2000 DA - 2000// TI - Tuberculosis of the central nervous system in children: a 20-year survey JO - J Infect VL - 41 UR - https://doi.org/10.1053/jinf.2000.0692 DO - 10.1053/jinf.2000.0692 ID - Farinha2000 ER - TY - JOUR AU - Marx, G. E. AU - Chan, E. D. PY - 2011 DA - 2011// TI - Tuberculous meningitis: diagnosis and treatment overview JO - Tuberc Res Treat VL - 2011 ID - Marx2011 ER - TY - JOUR AU - Peloquin, C. A. AU - Jaresko, G. S. AU - Yong, C. AU - Keung, A. C. F. AU - Bulpitt, A. M. Y. E. AU - Jelliffe, R. W. PY - 1997 DA - 1997// TI - Population Pharmacokinetic Modeling of Isoniazid, Rifampin, and Pyrazinamide JO - Antimicrob Agents Chemother VL - 41 ID - Peloquin1997 ER - TY - JOUR AU - Donald, P. R. PY - 2010 DA - 2010// TI - Cerebrospinal fluid concentrations of antituberculosis agents in adults and children JO - Tuberculosis VL - 90 UR - https://doi.org/10.1016/j.tube.2010.07.002 DO - 10.1016/j.tube.2010.07.002 ID - Donald2010 ER - TY - JOUR AU - Gundert-Remy, U. AU - Klett, M. AU - Weber, E. PY - 1973 DA - 1973// TI - Concentration of ethambutol in cerebrospinal fluid in man as a function of the non-protein-bound drug fraction in serum JO - Eur J Clin Pharmacol VL - 6 UR - https://doi.org/10.1007/BF00562440 DO - 10.1007/BF00562440 ID - Gundert-Remy1973 ER - TY - JOUR AU - Ellard, G. A. AU - Humphries, M. AU - Gabriel, M. AU - Teoh, R. PY - 1987 DA - 1987// TI - Penetration of pyrazinamide into the cerebrospinal fluid in tuberculous meningitis JO - Br Med J VL - 294 UR - https://doi.org/10.1136/bmj.294.6567.284 DO - 10.1136/bmj.294.6567.284 ID - Ellard1987 ER - TY - JOUR AU - Ruslami, R. AU - Ganiem, A. R. AU - Dian, S. PY - 2012 DA - 2012// TI - Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial JO - Lancet Infect Dis VL - 3099 ID - Ruslami2012 ER - TY - JOUR AU - Heemskerk, D. AU - Day, J. AU - Chau, T. T. H. PY - 2011 DA - 2011// TI - Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial JO - Trials VL - 12 UR - https://doi.org/10.1186/1745-6215-12-25 DO - 10.1186/1745-6215-12-25 ID - Heemskerk2011 ER - TY - JOUR AU - Toorn, R. AU - Schaaf, H. S. AU - Laubscher, J. a. AU - Elsland, S. L. AU - Donald, P. R. AU - Schoeman, J. F. PY - 2014 DA - 2014// TI - Short intensified treatment in children with drug-susceptible tuberculous meningitis JO - Pediatr Infect Dis J VL - 33 UR - https://doi.org/10.1097/INF.0000000000000065 DO - 10.1097/INF.0000000000000065 ID - Toorn2014 ER - TY - JOUR AU - Wolbers, M. AU - Heemskerk, D. AU - Chau, T. T. H. PY - 2011 DA - 2011// TI - Sample size requirements for separating out the effects of combination treatments: randomised controlled trials of combination therapy vs. standard treatment compared to factorial designs for patients with tuberculous meningitis JO - Trials VL - 12 UR - https://doi.org/10.1186/1745-6215-12-26 DO - 10.1186/1745-6215-12-26 ID - Wolbers2011 ER - TY - STD TI - Guidance for national tuberculosis programmes on the management of tuberculosis in children. WHO report 2006. Geneva, World Health Organization, 2006 (WHO/HTM/TB/2006.371 - WHO/FCH/CAH/2006.7). ID - ref11 ER - TY - JOUR AU - Thwaites, G. E. PY - 2004 DA - 2004// TI - Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults JO - N Engl J Med VL - 531 UR - https://doi.org/10.1056/NEJMoa040573 DO - 10.1056/NEJMoa040573 ID - Thwaites2004 ER - TY - JOUR AU - Brans, R. AU - Laizane, D. AU - Khan, A. AU - Blömeke, B. PY - 2004 DA - 2004// TI - N-acetyltransferase 2 genotyping: an accurate and feasible approach for simultaneous detection of the most common NAT2 alleles JO - Clin Chem VL - 50 UR - https://doi.org/10.1373/clinchem.2003.027748 DO - 10.1373/clinchem.2003.027748 ID - Brans2004 ER - TY - JOUR AU - Rihs, H. -. P. AU - John, A. AU - Scherenberg, M. AU - Seidel, A. AU - Brüning, T. PY - 2007 DA - 2007// TI - Concordance between the deduced acetylation status generated by high-speed: real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay JO - Clin Chim acta VL - 376 UR - https://doi.org/10.1016/j.cca.2006.08.010 DO - 10.1016/j.cca.2006.08.010 ID - Rihs2007 ER - TY - JOUR AU - Kilbane, a. J. AU - Silbart, L. K. AU - Manis, M. AU - Beitins, I. Z. AU - Weber, W. W. PY - 1990 DA - 1990// TI - Human N-acetylation genotype determination with urinary caffeine metabolites JO - Clin Pharmacol Ther VL - 47 UR - https://doi.org/10.1038/clpt.1990.59 DO - 10.1038/clpt.1990.59 ID - Kilbane1990 ER - TY - JOUR AU - Notarianni, L. J. AU - Dobrocky, P. AU - Godlewski, G. AU - Jones, R. W. AU - Bennett, P. N. PY - 1996 DA - 1996// TI - Caffeine as a metabolic probe: NAT2 phenotyping JO - Br J Clin Pharmacol VL - 41 UR - https://doi.org/10.1111/j.1365-2125.1996.tb00178.x DO - 10.1111/j.1365-2125.1996.tb00178.x ID - Notarianni1996 ER - TY - JOUR AU - Tiwari, G. AU - Tiwari, R. PY - 2010 DA - 2010// TI - Bioanalytical method validation: An updated review JO - Pharm Methods VL - 1 UR - https://doi.org/10.4103/2229-4708.72226 DO - 10.4103/2229-4708.72226 ID - Tiwari2010 ER - TY - STD TI - Prahl JB, Johansen IS, Cohen AS, Frimodt-Møller N, Andersen AB. Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study. J Antimicrob Chemother. 2014;69:2841–7. ID - ref18 ER - TY - JOUR AU - Ruslami, R. AU - Nijland, H. M. J. AU - Alisjahbana, B. AU - Parwati, I. AU - Crevel, R. AU - Aarnoutse, R. E. PY - 2007 DA - 2007// TI - Pharmacokinetics and tolerability of a higher rifampin dose versus the standard dose in pulmonary tuberculosis patients JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.01550-06 DO - 10.1128/AAC.01550-06 ID - Ruslami2007 ER - TY - JOUR AU - Reynolds, J. AU - Heysell, S. K. PY - 2014 DA - 2014// TI - Understanding pharmacokinetics to improve tuberculosis treatment outcome JO - Expert Opin Drug Metab Toxicol VL - 10 UR - https://doi.org/10.1517/17425255.2014.895813 DO - 10.1517/17425255.2014.895813 ID - Reynolds2014 ER - TY - JOUR AU - Mugabo, P. AU - Hassan, M. S. AU - Slaughter, R. PY - 2011 DA - 2011// TI - Acute Pharmacokinetics of First Line Anti-tuberculosis Drugs in Patients with Pulmonary Tuberculosis and in Patients with Pulmonary Tuberculosis Co-infected with HIV JO - J US-China Med Sci VL - 8 ID - Mugabo2011 ER - TY - STD TI - Mitchison DA, Davies GR. Assessment of the Efficacy of New Anti-Tuberculosis Drugs. Open Infect Dis J. 2008;2:59–76. ID - ref22 ER - TY - JOUR AU - Ramachandran, G. AU - Kumar, A. K. AU - Swaminathan, S. PY - 2011 DA - 2011// TI - Pharmacokinetics of anti-tuberculosis drugs in children JO - Indian J Pediatr VL - 78 UR - https://doi.org/10.1007/s12098-010-0304-x DO - 10.1007/s12098-010-0304-x ID - Ramachandran2011 ER - TY - JOUR AU - Ramachandran, G. AU - Hemanth Kumar, A. K. AU - Bhavani, P. K. PY - 2013 DA - 2013// TI - Age, nutritional status and INH acetylator status affect pharmacokinetics of anti-tuberculosis drugs in children JO - Int J Tuberc Lung Dis VL - 17 UR - https://doi.org/10.5588/ijtld.12.0628 DO - 10.5588/ijtld.12.0628 ID - Ramachandran2013 ER - TY - JOUR AU - Peloquin, C. A. PY - 2002 DA - 2002// TI - Therapeutic drug monitoring in the treatment of tuberculosis JO - Drugs VL - 62 UR - https://doi.org/10.2165/00003495-200262150-00001 DO - 10.2165/00003495-200262150-00001 ID - Peloquin2002 ER - TY - JOUR AU - Foster, B. J. AU - Platt, R. W. AU - Zemel, B. S. PY - 2012 DA - 2012// TI - Development and validation of a predictive equation for lean body mass in children and adolescents JO - Ann Hum Biol VL - 39 UR - https://doi.org/10.3109/03014460.2012.681800 DO - 10.3109/03014460.2012.681800 ID - Foster2012 ER - TY - JOUR AU - Pouplin, T. AU - Phuong, P. N. AU - Toi, P. AU - Nguyen Pouplin, J. AU - Farrar, J. PY - 2014 DA - 2014// TI - Isoniazid, pyrazinamide and rifampicin content variation in split fixed-dose combination tablets JO - PLoS One VL - 9 UR - https://doi.org/10.1371/journal.pone.0102047 DO - 10.1371/journal.pone.0102047 ID - Pouplin2014 ER - TY - JOUR AU - Donald, P. R. AU - Maritz, J. S. AU - Diacon, A. H. PY - 2012 DA - 2012// TI - Pyrazinamide pharmacokinetics and efficacy in adults and children JO - Tuberculosis VL - 92 UR - https://doi.org/10.1016/j.tube.2011.05.006 DO - 10.1016/j.tube.2011.05.006 ID - Donald2012 ER - TY - JOUR AU - Rey, E. AU - Gendrel, D. AU - Treluyer, J. M. PY - 2001 DA - 2001// TI - Isoniazid pharmacokinetics in children according to acetylator phenotype JO - Fundam Clin Pharmacol VL - 15 UR - https://doi.org/10.1046/j.1472-8206.2001.00044.x DO - 10.1046/j.1472-8206.2001.00044.x ID - Rey2001 ER - TY - JOUR AU - Schaaf, H. S. AU - Parkin, D. P. AU - Seifart, H. I. PY - 2005 DA - 2005// TI - Isoniazid pharmacokinetics in children treated for respiratory tuberculosis JO - Arch Dis Child VL - 90 UR - https://doi.org/10.1136/adc.2004.052175 DO - 10.1136/adc.2004.052175 ID - Schaaf2005 ER - TY - JOUR AU - Thee, S. AU - Seddon, J. A. AU - Donald, P. R. PY - 2011 DA - 2011// TI - Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations JO - Antimicrob Agents Chemother VL - 55 UR - https://doi.org/10.1128/AAC.05429-11 DO - 10.1128/AAC.05429-11 ID - Thee2011 ER - TY - JOUR AU - Mahmood, I. PY - 2014 DA - 2014// TI - Naive pooled-data approach for pharmacokinetic studies in pediatrics with a very small sample size JO - Am J Ther VL - 21 ID - Mahmood2014 ER - TY - JOUR AU - Graham, S. M. AU - Sismanidis, C. AU - Menzies, H. J. AU - Marais, B. J. AU - Detjen, A. K. AU - Black, R. E. PY - 2014 DA - 2014// TI - Importance of tuberculosis control to address child survival JO - Lancet VL - 6736 ID - Graham2014 ER - TY - STD TI - Marais BJ, Graham SM. Childhood tuberculosis: a roadmap towards zero deaths. Journal of Paediatrics and Child Health. 2014. doi:10.1111/jpc.12647. UR - http://ezproxy-prd.bodleian.ox.ac.uk:2111/doi/10.1111/jpc.12647/full ID - ref34 ER - TY - JOUR AU - Shingadia, D. PY - 2012 DA - 2012// TI - Tuberculosis in childhood JO - Ther Adv Respir Dis VL - 6 UR - https://doi.org/10.1177/1753465812436662 DO - 10.1177/1753465812436662 ID - Shingadia2012 ER - TY - JOUR AU - Well, G. T. J. AU - Paes, B. F. AU - Terwee, C. B. PY - 2009 DA - 2009// TI - Twenty Years of Pediatric Tuberculous Meningitis: A Retrospective Cohort Study in the Western Cape of South Africa JO - Pediatrics VL - 123 UR - https://doi.org/10.1542/peds.2008-1353 DO - 10.1542/peds.2008-1353 ID - Well2009 ER - TY - JOUR AU - Donald, P. R. PY - 2010 DA - 2010// TI - The chemotherapy of tuberculous meningitis in children and adults JO - Tuberculosis VL - 90 UR - https://doi.org/10.1016/j.tube.2010.07.003 DO - 10.1016/j.tube.2010.07.003 ID - Donald2010 ER - TY - JOUR AU - Thee, S. AU - Detjen, A. AU - Wahn, U. AU - Magdorf, K. PY - 2009 DA - 2009// TI - Rifampicin serum levels in childhood tuberculosis JO - Int J Tuberc Lung Dis VL - 13 ID - Thee2009 ER - TY - JOUR AU - Graham, S. M. AU - Bell, D. J. AU - Nyirongo, S. PY - 2006 DA - 2006// TI - Low Levels of Pyrazinamide and Ethambutol in Children with Tuberculosis and Impact of Age, Nutritional Status, and Human Immunodeficiency Virus Infection JO - Antimicrob Agents Chemother VL - 50 UR - https://doi.org/10.1128/AAC.50.2.407-413.2006 DO - 10.1128/AAC.50.2.407-413.2006 ID - Graham2006 ER - TY - JOUR AU - McLeay, S. C. AU - Morrish, G. A. AU - Kirkpatrick, C. M. J. AU - Green, B. PY - 2012 DA - 2012// TI - The relationship between drug clearance and body size: systematic review and meta-analysis of the literature published from 2000 to 2007 JO - Clin Pharmacokinet VL - 51 UR - https://doi.org/10.2165/11598930-000000000-00000 DO - 10.2165/11598930-000000000-00000 ID - McLeay2012 ER - TY - JOUR AU - Holford, N. PY - 1996 DA - 1996// TI - A size standard for pharmacokinetics JO - Clin Pharmacokinet VL - 30 UR - https://doi.org/10.2165/00003088-199630050-00001 DO - 10.2165/00003088-199630050-00001 ID - Holford1996 ER - TY - JOUR AU - Zhang, Y. AU - Mitchison, D. PY - 2003 DA - 2003// TI - The curious characteristics of pyrazinamide: a review JO - Int J Tuberc Lung Dis VL - 7 ID - Zhang2003 ER - TY - JOUR AU - Mitchison, D. A. PY - 2000 DA - 2000// TI - Role of individual drugs in the chemotherapy of tuberculosis JO - Int J Tuberc Lung Dis VL - 4 ID - Mitchison2000 ER - TY - JOUR AU - Donald, P. R. AU - Sirgel, F. A. AU - Venter, A. PY - 2004 DA - 2004// TI - The Influence of Human N-Acetyltransferase Genotype on the Early Bactericidal Activity of Isoniazid JO - Clin Infect Dis VL - 39 UR - https://doi.org/10.1086/424999 DO - 10.1086/424999 ID - Donald2004 ER - TY - JOUR AU - Donald, P. R. AU - Sirgel, F. A. AU - Botha, F. J. PY - 1997 DA - 1997// TI - The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis JO - Am J Respir Crit Care Med VL - 156 UR - https://doi.org/10.1164/ajrccm.156.3.9609132 DO - 10.1164/ajrccm.156.3.9609132 ID - Donald1997 ER - TY - JOUR AU - Jindani, A. AU - Aber, V. R. AU - Edwards, E. A. AU - Mitchison, D. A. PY - 1980 DA - 1980// TI - The early bactericidal activity of drugs in patients with pulmonary tuberculosis JO - Am Rev Respir Dis VL - 121 ID - Jindani1980 ER - TY - JOUR AU - McIlleron, H. AU - Willemse, M. AU - Werely, C. J. PY - 2009 DA - 2009// TI - Isoniazid plasma concentrations in a cohort of South African children with tuberculosis: implications for international pediatric dosing guidelines JO - Clin Infect Dis VL - 48 UR - https://doi.org/10.1086/598192 DO - 10.1086/598192 ID - McIlleron2009 ER - TY - JOUR AU - Diacon, A. H. AU - Patientia, R. F. AU - Venter, A. PY - 2007 DA - 2007// TI - Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears JO - Antimicrob Agents Chemother VL - 51 UR - https://doi.org/10.1128/AAC.01474-06 DO - 10.1128/AAC.01474-06 ID - Diacon2007 ER - TY - JOUR AU - Diacon, A. H. AU - Donald, P. R. PY - 2014 DA - 2014// TI - The early bactericidal activity of antituberculosis drugs JO - Expert Rev Anti Infect Ther VL - 12 UR - https://doi.org/10.1586/14787210.2014.870884 DO - 10.1586/14787210.2014.870884 ID - Diacon2014 ER - TY - JOUR AU - Steingart, K. R. AU - Jotblad, S. AU - Robsky, K. PY - 2011 DA - 2011// TI - Higher-dose rifampin for the treatment of pulmonary tuberculosis: a systematic review [Review article] JO - Int J Tuberc Lung Dis VL - 15 ID - Steingart2011 ER - TY - JOUR AU - te Brake, L. AU - Dian, S. AU - Ganiem, A. R. PY - 2015 DA - 2015// TI - Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis JO - Int J Antimicrob Agents VL - 45 UR - https://doi.org/10.1016/j.ijantimicag.2014.12.027 DO - 10.1016/j.ijantimicag.2014.12.027 ID - te Brake2015 ER - TY - JOUR AU - Mariappan, T. T. AU - Singh, S. AU - Pandey, R. AU - Khuller, G. K. PY - 2005 DA - 2005// TI - Determination of Absolute Bioavailability of Rifampicin by Varying the Mode of Intravenous Administration and the Time of Sampling JO - Clin Res Regul Aff VL - 22 UR - https://doi.org/10.1080/10601330500371524 DO - 10.1080/10601330500371524 ID - Mariappan2005 ER - TY - JOUR AU - Koup, J. R. AU - Williams-Warren, J. AU - Viswanathan, C. T. AU - Weber, A. AU - Smith, A. L. PY - 1986 DA - 1986// TI - Pharmacokinetics of rifampin in children. II. Oral bioavailability JO - Ther Drug Monit VL - 8 UR - https://doi.org/10.1097/00007691-198603000-00004 DO - 10.1097/00007691-198603000-00004 ID - Koup1986 ER -